KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Current Deferred Tax Assets (2016 - 2017)

Historic Current Deferred Tax Assets for Chemed (CHE) over the last 9 years, with Q3 2017 value amounting to $21.9 million.

  • Chemed's Current Deferred Tax Assets changed N/A to $21.9 million in Q3 2017 from the same period last year, while for Sep 2017 it was $21.9 million, marking a year-over-year change of. This contributed to the annual value of $8000.0 for FY2016, which is N/A changed from last year.
  • Per Chemed's latest filing, its Current Deferred Tax Assets stood at $21.9 million for Q3 2017.
  • Over the past 5 years, Chemed's Current Deferred Tax Assets peaked at $25.1 million during Q3 2013, and registered a low of $8000.0 during Q4 2016.
  • Over the past 5 years, Chemed's median Current Deferred Tax Assets value was $16.7 million (recorded in 2015), while the average stood at $16.4 million.
  • Per our database at Business Quant, Chemed's Current Deferred Tax Assets skyrocketed by 7779.43% in 2013 and then crashed by 4206.21% in 2014.
  • Chemed's Current Deferred Tax Assets (Quarter) stood at $20.3 million in 2013, then dropped by 23.91% to $15.4 million in 2014, then grew by 12.38% to $17.3 million in 2015, then plummeted by 99.95% to $8000.0 in 2016, then soared by 273562.5% to $21.9 million in 2017.
  • Its last three reported values are $21.9 million in Q3 2017, $20.6 million for Q2 2017, and $8000.0 during Q4 2016.